Mission accomplished . The 4 Amigos are finally a nonissue. They have zero credibility. Now we can discuss the matters at hand with the "REAL SHAREHOLDERS" that want more than anything to see Recaf commercialized. It is over, and the bashing will no longer have the effect that has plagued this company for years. Dr Moro should be pleased that all the questions that we ask are being submitted by shareholders that need clearity and by no means are trying to distract him or sabotage his accomplishments (unlike I-Hub).

Now a few questions for Dr Moro.

I would like to know if we are currently talking with any major cancer institutions, research centers, hospitals, or universities about our ELISA test or are you waiting for the ISOBM? Competition is healthy and expected with any product or service, but do you see any threats with any of the competing markers. This needs clarification. My belief is that we are unique in that it is a universal cancer marker. Isn't that what sets us apart from the competition? Wouldn't that make us the only test sensitive enough to become the only rapid test brought to the market? Thanks for creating this more civil environment and allowing for proper communications with your shareholders.